Bioaffinity Technologies Warrant Stock Alpha and Beta Analysis
| BIAFW Stock | USD 0.46 0.04 8.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as bioAffinity Technologies Warrant. It also helps investors analyze the systematic and unsystematic risks associated with investing in BioAffinity Technologies over a specified time horizon. Remember, high BioAffinity Technologies' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to BioAffinity Technologies' market risk premium analysis include:
Beta 0.76 | Alpha 0.88 | Risk 20.65 | Sharpe Ratio 0.0343 | Expected Return 0.71 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
BioAffinity |
BioAffinity Technologies Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. BioAffinity Technologies market risk premium is the additional return an investor will receive from holding BioAffinity Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in BioAffinity Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate BioAffinity Technologies' performance over market.| α | 0.88 | β | 0.76 |
BioAffinity Technologies expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of BioAffinity Technologies' Buy-and-hold return. Our buy-and-hold chart shows how BioAffinity Technologies performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.BioAffinity Technologies Market Price Analysis
Market price analysis indicators help investors to evaluate how BioAffinity Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioAffinity Technologies shares will generate the highest return on investment. By understating and applying BioAffinity Technologies stock market price indicators, traders can identify BioAffinity Technologies position entry and exit signals to maximize returns.
BioAffinity Technologies Return and Market Media
The median price of BioAffinity Technologies for the period between Fri, Nov 29, 2024 and Thu, Feb 27, 2025 is 0.52 with a coefficient of variation of 36.33. The daily time series for the period is distributed with a sample standard deviation of 0.21, arithmetic mean of 0.57, and mean deviation of 0.17. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Zannes Timothy P of 3619 shares of BioAffinity Technologies subject to Rule 16b-3 | 11/14/2024 |
2 | Acquisition by Edwards James Michael of 2448 shares of BioAffinity Technologies subject to Rule 16b-3 | 12/02/2024 |
3 | bioAffinitys CyPath Lung Test Drives Explosive 1,750 percent Sales Growth Projects Strong 2024 Revenue - StockTitan | 12/12/2024 |
4 | Disposition of 7142 shares by Zannes Maria of BioAffinity Technologies at 4.2 subject to Rule 16b-3 | 01/08/2025 |
5 | bioAffinity Technologies Announces Acceptance of Patent Application for Early-Stage Lung Cancer Diagnostic | 01/22/2025 |
6 | bioAffinity Technologies Announces Closing of Warrant Inducement Transaction for Aggregate Gross Proceeds of 1.4 Million | 02/26/2025 |
About BioAffinity Technologies Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including BioAffinity or other stocks. Alpha measures the amount that position in BioAffinity Technologies has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Payables Turnover | 0.001353 | 2.88 | 2.59 | 2.72 | Days Of Inventory On Hand | 4.3K | 3.88 | 4.46 | 4.23 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioAffinity Technologies in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioAffinity Technologies' short interest history, or implied volatility extrapolated from BioAffinity Technologies options trading.
Build Portfolio with BioAffinity Technologies
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for BioAffinity Stock Analysis
When running BioAffinity Technologies' price analysis, check to measure BioAffinity Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAffinity Technologies is operating at the current time. Most of BioAffinity Technologies' value examination focuses on studying past and present price action to predict the probability of BioAffinity Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAffinity Technologies' price. Additionally, you may evaluate how the addition of BioAffinity Technologies to your portfolios can decrease your overall portfolio volatility.